Introduction {#s1}
============

Globally, a large number of medicines are available for the treatment of pain and associated disorders. Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for the management of pain and inflammation due to their strong efficacy (Zarin et al., [@B64]). However, their use is associated with severe side effects. Alternatively, the drugs from natural origins are considered to be relatively safe and are associated with fewer unwanted effects. Natural products, especially the plants play a vital role in the discovery of new chemical entities with potential therapeutic values (Rates, [@B46]; Ayaz et al., [@B13]). The traditional use of plants is therefore a logical strategy to find out natural therapeutic agents for different ailments like pain and inflammation (Gupta et al., [@B32]). Despite the development of therapeutic agents for pain, there is still a demand to search out novel agents which could treat pain and related disorders more efficiently (Calixto et al., [@B18]).

The reactive oxygen species (ROS) are produced within the body as a result of redox processes and aerobic respiration. These ROS invade lipids, proteins, enzymes, DNA and RNA and ultimately damage the cells. These biomolecules play a vital role in stimulation, propagation and maintenance of inflammatory processes, as well as pain and neurodegenerative disorders (Zhu et al., [@B69]). These unwanted effects can be reduced by the use of antioxidants which either reduce the production of ROS or diminish them before reaction (Khalil et al., [@B39]; Cuzzocrea et al., [@B26]). In this regard, the essential oils isolated from herbal sources may be considered for the management of pain, inflammation, and free radicals scavenging. Several plants have been reported with strong antioxidant potentials against free radicals (Ahmad et al., [@B4]; Ayaz et al., [@B11]).

Alzheimer\'s disease (AD) is a common neurodegenerative disorder characterized by cognitive hypo-function, behavioral turbulence and difficulties in life activities (Ali et al., [@B10]; Ayaz et al., [@B14]). AD is believed to be the major cause of dementia in elder population (Ullah et al., [@B58]). According to the statistics, 27 million people are affecting globally from Alzheimer and is a major life threat after cancer and cardiovascular diseases (Hebert et al., [@B33]). AD pathogenesis include synaptic deficiency of essential neurotransmitter (acetylcholine, ACh) which is implicated in the neurotransmission (Sadiq et al., [@B49]). Other aspects of AD include accumulation of amyloid beta (Aβ), neurofibrillary tangles (NFTs), and free radicals induced neurodegeneration (McLean et al., [@B43]; Zeb et al., [@B66]; Ahmad et al., [@B5]). The inhibition of cholinesterase is a vital biochemical target involved in the degradation of ACh which increases its accumulation in the synaptic region. Among the five clinically approved anti-Alzheimer drugs, four are cholinesterase inhibitors while the fifth drug memantine is glutametergic system modifier. Despite the fact that several anti-amyloid and anti-NTFs drugs are in clinical trials, but, till date, no one is approved for clinical use. Furthermore, administration of free radical scavengers is also an important strategy, as Aβ is potent generator of free radicals and a mitochondrial poison. Plants are a source of mutli-potent drugs, including anti-AD drugs. Among the currently available anti-AD drugs, physostigmine, and galanthamine are derived from medicinal plants (Ahmad et al., [@B5]). Furthermore, natural products are free radicals\' scavengers and can be effective on multiple pathways (Ayaz et al., [@B15]).

*Isodon rugosus* Wall. ex. Benth. is a well-known species of family Labiateae. The bark of *I. rugosus* is used ethnomedicinally in the treatment of dysentery and curing of body pain (Shuaib et al., [@B54]). Folklorically, the fresh leaves\' extract of *I. rugosus* is applied to the effected skin and is also used for earache (Sabeen and Ahmad, [@B47]). Moreover, the dried leaves of this plant can be used for the treatment of teeth pain (Akhtar et al., [@B8]). The plant has also been reported to posses potential effectiveness in gastric and abdominal pains (Ahmad et al., [@B3]). Moreover, other traditional uses of *I. rugosus* are attributed to its possible use against infectious diseases, pyrexia, blood pressure, rheumatism, and in pain associated with teeth (Khan and Khatoon, [@B40]; Adnan et al., [@B2]; Shuaib et al., [@B55]). The extracts of *Isodon rugosus* have been previously published to posses certain biological potentials like anti-diarrheal, analgesic, antimicrobial, anticholinesterase, antioxidant, cytotoxic, phytotoxic, hypoglycemic, and as bronchodilator (Sher et al., [@B53]; Ajmal et al., [@B7]; Janbaz et al., [@B37]; Zeb et al., [@B66],[@B67], [@B65], [@B68]).

Based on the ethnomedicinal importance and our previously published work, this piece of research is designed to investigate the *in-vivo* analgesic mechanism, *in-vitro* antioxidant, and anti-cholinesterase activities of essential oils of *Isodon rugosus*.

Methods {#s2}
=======

Plant sample collection & isolation of essential oil
----------------------------------------------------

*Isodon rugosus* was collected from Dir (L), KP, Pakistan in July. The name *Isodon rugosus* was confirmed by Dr. Ali Hazrat, Department of Botany, Shaheed Benazir Bhutto University Dir (U), KP, Pakistan. The plant sample was stored for future record at the herbarium with voucher specimen number 1016AZ. The essential oils were extracted by hydrodistillation with the help of a Clevenger type apparatus (Lambert et al., [@B42]). The isolated essential oils were stored in refrigerator.

Gas chromatography analysis
---------------------------

The phytocomponents of essential oils were separated using the same GC instrument as we previously reported (Ahmad et al., [@B5]). A capillary column having dimensions of 30 m × 0.25 mm with film thickness of 0.25 μm in combination with a flame ionization detector was used. The initial temperature was 70°C for 1 min, which was raised gradually to 180°C with 6°C/min increase for 5 min. Finally, the oven temperature was increased to 280°C with 5°C/min increase for 20 min. Temperature of the injector port was 220°C while that of detector was maintained at 290°C. Helium was used as a carrier gas. The sample was diluted in *n*-pentane (1/1,000, v/v) of 1 μl (Ayaz et al., [@B12]).

GC-MS analysis
--------------

The GC-MS analysis of essential oil isolated from *Isodon rugosus* was determined with the previously reported parameters (Ayaz et al., [@B11]).

Identification of components
----------------------------

The retention times and spectra of separated compounds by GC-MS were compared with the standard compounds for identifications. The mass spectrum of each separated compound with its fragmentation pattern was compared with the reported compounds (Stein et al., [@B56]; Adams, [@B1]).

Experimental animals
--------------------

The Swiss albino mice of either sex were used in analgesic experiments which were obtained from research laboratory of National Institute of Health, Islamabad, Pakistan. The animals were used as per the approval of the ethical committee, Department of Pharmacy, University of Malakand, Pakistan according to the animals Bye-Laws 2008 (Scientific Procedure Issue-1).

Acute toxicity
--------------

Swiss albino mice were taken in various groups, having 5 test animals in each group. The essential oil samples were administered to the animals orally in different doses (250--2,000 mg/kg). To increase the aqueous solubility of essential oil, 0.1% v/v tween-80 (Sigma Aldrich)- was used. After administration of the doses, animals were critically observed for 72 h for hypersensitivity, abnormal behavior, and death. The experimental animals were observed for 20 days for sub-chronic effects and lethality (Hosseinzadeh et al., [@B35]).

Analgesic activities
--------------------

### Acetic acid-induced writhing test

In acetic acid induced writhing test, the essential oil was administered orally (PO) in the same concentrations as mentioned in above section. After 30 min of interval, acetic acid (0.6%, 10 ml/kg) was injected into the mice intra-peritoneally. Tween-80 (0.5%, 3 ml/kg) was administered to Group I animals. The Group I was used as a negative control. The standard drug diclofenac sodium was administered to Group II with a dose of 10 mg/kg. The essential oil samples were administered to Groups III and IV in concentrations of 50 and 100 mg/kg respectively. After administration of acetic acid, the number of writhes were counted for 30 min (Franzotti et al., [@B31]).

### Formalin test

The formalin-induced licking test of Ir.EO was carried out using Swiss albino mice weighing 25--30 gm. The test was performed in a controlled environmental temperature (23 ± 2°C) with light-dark cycle of 12 h each. Food and water was freely available to the test animals throughout the investigations. The essential oil was administered intraperitonially (I/P) to the experimental animals at various concentrations. After 30 min, 20 μl formalin (2.5%, v/v in distilled water) was injected subcutuneously (S/C) into the plantar surface of the hind paw. Tween-80 (0.5%, 3 ml/kg), a negative control in the experiment was administered to the Group I. Morphine (5 mg/kg), a standard drug, was administered to Group II animals. The animals in Groups III and IV were injected Ir.EO at concentrations of 50 and 100 mg/kg respectively. The nociceptive behavior was designated by formalin-induced licking of paw. The total time taken in the behavioral changes of the mice responses to nociception was recorded, such as licking and/or biting of the injected paw. The time taken was recorded for 30 min. The initial 5 min were considered as early phase, while 2nd period (15--30 min) as the late phase of the response. The early and late phase are termed as neurogenic and inflammatory phase, respectively (Sulaiman et al., [@B57]).

### Hot plate test

The hot plate test method was assessed for the antinociception potential of essential oil isolated from *I. rugosus* as per the reported procedure (Zeb et al., [@B65]). In this method, a heated surface of a hot plate analgesia meter (Ugo Basile, model-7280) was maintained at 55 ± 0.2°C. The animals were kept over a heated surface in a closed glass cylinder. The time of the animals\' placement and licking of hind paw or jumping over the heated surface were recorded as response latency. These are the parameters as a result of the thermal reactions. The oil samples, in concentrations of 50 and 100 mg/kg, while morphine 5 mg/kg, i.p., were administered 30 min before the beginning of the assessment. Mice were observed before administration of samples, and then at 30, 60 and 90 min after the samples taken. The cut-off time was 20 s.

### Involvement of opioid receptors

This experiment was carried out to confirm the possible involvement of opioid receptors in the essential oil-induced antinociception. The procedure was evaluated using a hot plate and formalin test method as mentioned earlier. In this method, different groups of experimental mice (*n* = 6) were pretreated with naloxone (5 mg/kg, S/C), which is a non-selective opioid receptor antagonist. Naloxone was injected 15 min before the administration of Ir.EO and morphine.

Antioxidant assays
------------------

### DPPH assay

The DPPH free radicals scavenging effect was figured out for Ir.EO as previously published (Shah et al., [@B52]). The DPPH solution (0.004%) in methanol was prepared which appeared with a deep violet color. Initially, the stock solution of essential oil with a known concentration of 1,000 μg/mL was prepared in ethanol. Then, this solution was diluted serially to obtain different concentrations from 62.5 to 1,000 μg/mL. Afterwards, 0.1 mL of the serially diluted concentration was added to 3.0 mL of DPPH solutions. This mixture was stored at dark place for 30 min at 23°C. After 30 min, the absorbance of each oil sample was measured by using double beam spectrophotometer at a wavelength of 517 nm. Ascorbic acid served as a positive control. The percent activity of all the samples was recorded as mean ± SEM. The percent radical scavenging potential was figured out using the following formula;
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### ABTS assay

Antioxidant potential of Ir.EO was also investigated using free radicals of 2, 2-azinobis \[3-ethylbenzthiazoline\]-6-sulfonic acid (ABTS) (Ullah et al., [@B59]). Solutions of ABTS (7 mM) and potassium persulfate (2.45 mM) were prepared and mixed thoroughly. The prepared solution was stored in a dark place overnight to generate free radicals. The absorbance of this solution was adjusted at 745 nm to 0.7 by addition methanol (50%). ABTS solution 3 mL was added to the test tubes containing samples having volume of 300 μL. The solution was transferred to the sample holder and absorbance was recorded for 6 min by using a double beam spectrophotometer. Ascorbic acid was used as a standard. The percent ABTS free radicals scavenging potential of the oil sample was measured by using the given formula;
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### Anticholinesterase assays

Cholinesterases inhibitory potentials of Ir.EO was evaluated following Ellman\'s assay (Ellman et al., [@B30]). This procedure is based on enzymatic breakdown of substrates like acetylthiocholine iodide and butyrylthiocholine iodide by AChE and BChE respectively to form 5-thio-2-nitrobenzoate anions. The resultant anions consequently form a complex with DTNB and are converted into UV detectable yellow color compound. The formation of this compound is quantified in the presence and absence of inhibitor agents. In brief, 5 μL enzyme solution was added to each well of micro plate with subsequent addition of 5 μL DTNB solution. The resulting mixture was incubated for fifteen min at 30°C in water bath, and finally 5 μl substrate solution was added to it. At the end, absorbances were recorded at 412 nm. The control samples were the same as above mentioned but were without inhibitors. The change in absorbance was observed beside reaction time. The activity of enzymes and its inhibitory activities were determined for control as well as test samples from the rate of absorption with change in time as, V = Δ Abs /Δ t, and enzyme inhibition as;
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Where, V~max~ is enzyme activity in the absence of inhibitor agent.

### Estimation of IC~50~ values

The median inhibitory concentration (IC~50~) values of DPPH, ABTS, AChE, and BChE inhibitory assays were find out by linear regression analysis of the percent inhibition versus concentrations of the test samples through MS Excel program (Shah et al., [@B51]; Sadiq et al., [@B48]).

Statistical data analysis
-------------------------

The values of all the tests were tabulated as mean ± S.E.M. Significant differences of the percent inhibitions of various test samples were analyzed via one way ANOVA following Bonferroni\'s post-test using GraphPad Prism software in which the *P* \< 0.05 were considered significant.

Results {#s3}
=======

GC-MS analysis
--------------

The essential oil of *Isodon rugosus* was subjected to GC-MS analysis and total of 141 compounds were identified. On the given GC method, the retention times of the identified compounds were from 6.057 to 81.661 min. The details of all identified compounds are given in Table [1](#T1){ref-type="table"}.

###### 

List of all the compounds identified in the GC-MS analysis of essential oil of *Isodon rugosus*.

  **S. No**.   **Compound label**                                                                  **RT**   **Name**                   **Formula**   **Hits (DB)**
  ------------ ----------------------------------------------------------------------------------- -------- -------------------------- ------------- ---------------
  1            Methyl ethyl ketone                                                                 6.057    Butanone                   C4H8O         10
  2            2-cyclohexenyl vinyl ether                                                          6.683    Na                         C8H12O        10
  3            Alpha.-Copaene                                                                      18.689   Alpha Copaene              C15H24        10
  4            BETA-bOURBONENE                                                                     19.522   BETA. BOURBONENE           C15H24        10
  5            8-Isopropyl-1-methyl-5-methylene-1,6-cyclodecadiene                                 19.605   Germacrene D               C15H24        10
  6            2,6-Dimethylocta-1,4,7-triene                                                       19.643   Cis-Achillene              C10H16        10
  7            2-Butanone, 4-(2,2-dimethyl-6-methylenecyclohexyl)                                  19.764   Na                         C13H22O       10
  8            Bicyclo\[3,3,1\]non-2-ene, 7-oxa-2,8,9-trimethyl-5-acetoxymethyl                    19.866   Na                         C14H22O3      10
  9            1,4-Dimethylpent-2-enyl)benzene                                                     19.976   Na                         C13H18        10
  10           Beta.-Caryophyllen                                                                  20.312   Caryophyllene              C15H24        10
  11           1,1,7-TRIMETHYL-4-METHYLENEDECAHYDRO-1H-CYCLOPROPA\[E\]AZULENE                      20.584   AROMADENDRENE              C15H24        10
  12           Alpha.-Cubebene                                                                     20.851   Alpha Cubebene             C15H24        10
  13           CADINA-1,4-DIENE                                                                    20.937   Na                         C15H24        10
  14           3,8-Dimethylundecane                                                                20.98    Na                         C13H28        10
  15           Cycloisolongifolene, 8,9-dehydro-                                                   21.184   Na                         C15H22        10
  16           Epi-bicyclosesquiphellandrene                                                       21.227   Na                         C15H24        10
  17           Alpha.-Amorphene                                                                    21.477   Alpha Amorphene            C15H24        10
  18           Benzene, 1-(1,5-dimethyl-4-hexenyl)-4-methyl                                        21.549   Ar-Curcumene               C15H22        10
  19           Cis-(-)-2,4a,5,6,9a-Hexahydro-3,5,5,9-tetramethyl(1H)benzocycloheptene              21.626   Na                         C15H24        10
  20           7-Methoxy-1,2,3,4-tetrahydro-9H-pyrido\[3,4-b\]indole                               21.788   Na                         C12H14N2O     6
  21           Cadina-4,9-diene                                                                    21.977   Alpha.-Muurolene           C15H24        10
  22           1-Hydroxy-1,7-dimethyl-4-isopropyl-2,7-cyclodecadiene                               22.452   Germacrene D-4-ol          C15H26O       10
  23           Calamenene                                                                          22.479   Calamenene                 C15H22        10
  24           9-Methyl-S-octahydrophenanathracene                                                 22.603   Na                         C15H20        10
  25           2,5,9,9-Tetramethyl-6,7,8,9-tetrrahydro-5H-benzocycloheptane                        22.775   Na                         C15H22        10
  26           5H-Inden-5-one, 1,2,3,3a,4,7a-hexahydro-7a-methyl-, trans-                          22.823   Na                         C10H14O       10
  27           1,1,6-trimethyl-1,2-dihydro naphthalene                                             22.917   CALACORENE                 C13H16        10
  28           3-Heptadecen-5-yne                                                                  23.126   Na                         C17H30        10
  29           1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl                                           23.471   Trans-Nerolidol            C15H26O       10
  30           6-Pentadecen-9-yne                                                                  23.885   Na                         C15H26        10
  31           Verbenene                                                                           23.923   Verbenene                  C10H14        10
  32           N-Butyl-3-hydroxybutyramide                                                         24.061   Na                         C8H17NO2      3
  33           N-(1-Methylethyl)-2-(1-methylethyl)benzamide                                        24.073   Na                         C13H19NO      10
  34           Clov-2-ene-9.alpha.-ol                                                              24.145   Na                         C15H24O       10
  35           VIRIDIFLOROL                                                                        24.221   Veridiflorol               C15H26O       10
  36           Ledol                                                                               24.319   Ledol                      C15H26O       10
  37           1H-Inden-1-one, octahydro-, cis                                                     24.462   Hydrindan                  C9H14O        10
  38           3-(Hydroxymethyl)-4-hydroxy-5,6,7,8-tetrahydroquinoline                             24.531   Na                         C10H13NO2     3
  39           1,2-Naphthalenedione, 3,8-dimethyl-5-(1-methylethyl)                                24.561   Mansonone C                C15H16O2      10
  40           Humulane-1,6-dien-3-ol                                                              24.618   Na                         C15H26O       10
  41           Cedr-8-ene                                                                          24.696   Alfa-cedrene               C15H24        10
  42           Longifolenaldehyde                                                                  24.781   Longifolenaldehyde         C15H24O       10
  43           2,3-Bis\[(adamantylcarbonyl)ethynyl\]bicyclo\[2.2.1\]hepta-2,5-diene                24.993   Na                         C33H36O2      10
  44           1,2-Diacetyl-4-methylbenzene                                                        25.134   Na                         C11H12O2      10
  45           1.beta.,10.beta.H-Cadin-4-en-10-ol                                                  25.392   T-Muurolol                 C15H26O       3
  46           4,4-Dimethylpentanenitrile                                                          25.406   Na                         C7H13N        1
  47           Cadin-4-en-10-ol                                                                    25.57    Alpha.-Cadinol             C15H26O       10
  48           5,7-Dimethylquinoline                                                               25.583   Na                         C11H11N       10
  49           Azulene, 1,4-dimethyl-7-(1-methylethyl)                                             25.686   Azunol                     C15H18        10
  50           1,4-Methanobenzocyclodecene, 1,2,3,4,4a,5,8,9,12,12a-decahydro-                     25.864   Na                         C15H22        5
  51           4,4a,5,6,7,8-Hexahydro-4a-methyl-2(3H)-naphthalenone                                26.157   Na                         C11H16O       10
  52           7,7-dichlorobicyclo\[3.2.0\]hept-2-en-6-one                                         26.262   Na                         C15H24O       10
  53           6-Methylenebicyclo\[2.2.1\]hept2-en-1-ol                                            26.348   Na                         C8H10O        1
  54           MUUROLA-4,10(14)-DIEN-3-ONE                                                         26.374   Na                         C15H22O       10
  55           Pentalene, octahydro-1-(2-octyldecyl)                                               26.513   Na                         C26H50        10
  56           1.beta.,4.beta.H,10.beta.H-Guaia-5,11-diene                                         26.627   Gamma.-Gurjunene           C15H24        10
  57           Phosphorochloridic acid, diethyl ester                                              26.788   Diethyl chlorophosphate    C4H10ClO3     10
  58           Isoisopulegyl acetate                                                               26.902   Isoisopulegyl acetate      C12H20O2      10
  59           1,3-dimethyl-3-acetoxymethyl-2-oxabicyclo\[2.2.2\]octan-5-one                       27.314   Na                         C12H18O4      10
  60           Benzyl benzoate                                                                     27.873   Benzyl benzoate            C14H12O2      10
  61           Ttrans-1-(3′′-Cyclopropylidenepropen-1′′-yl)-1-(propen-3′-yl)cyclopropane           28.23    Na                         C12H16        5
  62           Ethyl 3-phenylhexa-2,4-dienoate                                                     29.066   Na                         C14H16O2      4
  63           1-(6′-Methoxy-7′-methyl-1′,2′,3′,4′-tetrahydronaphthalen-1′-yl)ethanol              29.312   Na                         C14H20O2      2
  64           6-(p-Tolyl)-2-methyl-2-heptenol                                                     29.584   Nuciferol                  C15H22O       10
  65           2-Butanol, 4-\[2,2,6-trimethylcyclohexyl\]-, acetate                                30.058   Tetrahydroionyl acetate    C15H28O2      10
  66           1H-3a,7-Methanoazulene, octahydro-1,4,9,9-tetramethyl                               30.327   Patchoulane                C15H26        10
  67           Trans-Pinocarvyl acetate                                                            30.688   Na                         C12H18O2      3
  68           \[1-(R,S),5(R,S)\]-3-(2,2-dimethyl-1-(R,S/S,R)-hydroxypropyl)-6-(R,S)-n-octyl-...   31.48    Na                         C18H32O3      4
  69           3-Angelate of felikiol                                                              31.704   Na                         C20H32O4      1
  70           2-thia-6-methyl-7-(2-formylethyl)bicyclo\[3.2.0\]hept-6-ene-2,2-dioxide             31.795   Na                         C10H14O3S     3
  71           Aphanamol                                                                           32.079   Aphanamol                  C15H24O2      10
  72           5,9-Undecadien-2-one, 6,10-dimethyl                                                 32.317   Geranylacetone             C13H22O       10
  73           4-Chlorobutyric acid, octadecyl ester                                               32.639   Na                         C22H43ClO2    10
  74           Bicyclo\[5.2.0\]nonane, 4-methylene-2,8,8-trimethyl-2-vinyl-                        32.976   Na                         C15H24        10
  75           2,9-Dimethyl-8-oxatetracyclo\[5.4.1.1(3,10).0(5,9)\]tridecane-2-endo,7-diol         33.499   Na                         C14H22O3      10
  76           1-(4-Hydroxy-3-isopropenyl-4,7,7-trimethyl-cyclohept-1-enyl)-ethanone               33.918   Na                         C15H24O2      7
  77           1,2-pentanediol, 5-(6-bromodecahydro-2-hydroxy-2,5,5a,8a-tetramethyl-1-napht...     34.228   Na                         C20H35BrO3    1
  78           1-Hydroxy-1,7-dimethyl-4-isopropyl-2,7-cyclodecadiene                               35.087   Na                         C15H26O       1
  79           Viridiflorene                                                                       35.376   Viridiflorene              C15H24        8
  80           Dodecylpalmitate                                                                    35.978   Dodecylpalmitate           C28H56O2      10
  81           Sec-Butyl 2,3,4,6-tetra-methyl-.beta.,D-galactopyranoside isomer                    36.292   Na                         C14H28O6      2
  82           1,3-EPIMANOYL OXIDE                                                                 36.366   Epimanoyl oxide            C20H34O       8
  83           Pentadecane                                                                         36.435   Pentadecane                C15H32        10
  84           Cyclodecane, octyl                                                                  36.599   Octylcyclodecane           C18H36        5
  85           Labd-14-ene, 8,13-epoxy-, (13R)-                                                    37.211   Na                         C20H34O       10
  86           5.alpha.-allyl-6.alpha.-hydroxy-5.beta.,9.beta.-dimethyl-trans-decalin-1-one        37.726   Na                         C15H24O2      3
  87           Naphthalene, 7-butyl-1-hexyl                                                        38.181   Na                         C20H28        10
  88           1,1,7,12-tetramethyl-8-ethyl-1,2,3,4,9,10,11,12-octahydrophenanthrene               38.718   Na                         C20H30        10
  89           Benzamidine, 4-(4-pentylphenyl)-                                                    39.442   Na                         C18H22N2      1
  90           3-Eicosene                                                                          39.652   Na                         C20H40        10
  91           Eicosane                                                                            40.011   Eicosane                   C20H42        10
  92           Sulfurous acid, hexyl nonyl ester                                                   40.208   Na                         C15H32O3S     10
  93           2-Cyclohexen-1-ol, 3-methyl-6-(1-methylethyl)                                       40.372   Na                         C10H18O       10
  94           1-Acetyl-2-amino-3-cyano-7-isopropyl-4-methylazulene                                40.546   Na                         C17H18N2O     1
  95           2-Hexadecen-1-ol, 3,7,11,15-tetramethyl                                             40.682   Phytol                     C20H40O       10
  96           1,1,8,9A-tetramethyl-2,3,5,6,7,9a-hexahydro-1h-benzo\[a\]cycloheptene               40.915   Na                         C15H24        10
  97           2-n-Heptylcyclopentanone                                                            41.419   Na                         C12H22O       10
  98           7,11,15-TRIMETHYL,3-METHYLENE-1-HEXADECENE                                          41.645   Neophytadiene              C20H38        10
  99           Stearic acid                                                                        42.294   Stearic acid               C18H36O2      10
  100          Abietyl alcohol, dehydro                                                            42.844   Abietyl alcohol, dehydro   C20H30O       2
  101          Oxalic acid, hexadecyl propyl ester                                                 43.093   Na                         C21H40O4      7
  102          1,4a.beta.-Dimethyl-7-isopropyl-2,3,4,4a,9,10-hexahydrophenanthrene                 43.238   Na                         C19H26        10
  103          5-Diazo-1-(2′-methyl-4′-nitrophenylazo)-1,3-cyclopentadiene                         43.79    Na                         C12H9N5O2     10
  104          (1.alpha.,2a.alpha.,8b.alpha.)-1,2,2a,8b-Tetrahydro-8b-hydroxy-1                    44.228   Na                         C17H13NO      10
  105          2-Methyl-5,6-diphenyl-1,2,4-triazin-3(2H)-one                                       44.27    Na                         C16H13N3O     1
  106          Dehydroabietal                                                                      44.302   Dehydroabietal             C20H28O       3
  107          8-Methoxy-4-methylbenzo\[g\]quinoline-5,10-dione                                    44.617   Na                         C15H11NO3     10
  108          Phenol, 4-methoxy-2-\[5-(4-methylphenyl)-3-pyrazolyl)-                              45.092   Na                         C17H16N2O2    10
  109          Pentatriacontane                                                                    45.127   Pentatriacontane           C35H72        10
  110          Tetracyclo\[16.1.0.0(2,9).0(10,17)\]nonadeca-2(9),10(17)-diene, 19,19-dimethyl-     45.232   Na                         C21H32        10
  111          1,2-Dihydro-1-methyl-2-trifluoroacetylmethylenequinoline                            45.506   Na                         C13H10F3NO    10
  112          Simvastatin                                                                         45.671   Simvastatin                C25H38O5      3
  113          Methyl-9-anthracenemethanamine                                                      45.764   Na                         C16H15N       7
  114          4,8,12,16-Tetramethylheptadecan-4-olide                                             46.318   Na                         C21H40O2      2
  115          2-Ethyl-3-phenyl-2-butene-1-al                                                      47.678   Na                         C12H14O       2
  116          Hinokione methyl ether                                                              47.827   Hinokione methyl ether     C21H30O2      10
  117          8-Isopropyl-1,3-dimethylphenanthrene                                                47.873   Na                         C19H20        1
  118          Cyclohexanone, 2-butyl                                                              48.334   Na                         C10H18O       10
  119          17-Methoxy-d-homo-18-norandrosta-4,8,13,15,17-pentaen-3-one                         48.756   Na                         C20H22O2      10
  120          5,8,11,14-Eicosatetraynoic acid, methyl ester                                       48.899   Na                         C21H26O2      4
  121          MARGOCIN                                                                            48.964   MARGOCIN                   C20H26O2      1
  122          Phenanthro\[3,2-b\]furan-7,11-dione, 1,2,3,4-tetrahydro-4,4,8-trimethyl-            49.337   Na                         C19H18O3      10
  123          1,4-Bis(2-chloro-1,1-dimethylethyl)benzene                                          49.547   Na                         C14H20Cl2     2
  124          Phenol, 4-methoxy-2-\[5-(4-methylphenyl)-3-pyrazolyl)-                              49.67    Na                         C17H16N2O2    10
  125          6-Hydroxy-2,2,5,7,8-pentamethyl-4-phenyl-2H-1-benzopyran                            50.552   Na                         C20H22O2      10
  126          Phenanthro\[3,2-b\]furan-7,11-dione, 1,2,3,4-tetrahydro-4,4,8-trimethyl-            51.077   Na                         C19H18O3      10
  127          2-Phosphabicyclo\[3.1.0\]hex-3-ene, 2,6,6-trimethyl-3,4-diphenyl-                   51.481   Na                         C20H21P       5
  128          2,3-(anti)-Epoxy-1,4-dimethyl-1,4,6,13-tetrahydrobenzo\[g\]pyridazino\[1,2-b\]      51.743   Na                         C18H16N2O3    1
  129          Benzenamine, N,N-diethyl-4-\[2-(4-nitrophenyl)ethenyl\]-                            52.901   Na                         C18H20N2O2    10
  130          2,6-Bis(1,1-dimethylethyl)-4-phenylmethylenecyclohexa-2,5-dien-1-one                53.235   Na                         C21H26O       9
  131          2H-Pyrazole, 3-amino-5-methyl-2-(4-nitrophenyl)-4-phenyl-                           53.378   Na                         C16H14N4O2    10
  132          1-(2-Isopropyl-phenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-indazol-4-one             53.687   Na                         C19H24N2O     10
  133          3-(N,N-Diethylamino)-5-iodoaniline                                                  54.347   Na                         C10H15IN2     10
  134          17-Methoxy-d-homo-18-norandrosta-4,8,13,15,17-pentaen-3-one                         54.378   Na                         C20H22O2      1
  135          Heneicosane, 11-(1-ethylpropyl)                                                     56.17    Na                         C26H54        3
  136          2-nitro-5a,6,6-trimethyl-5a,6-dihydro-12h-indolo\[2,1-b\]\[1,3\]benzoxazine         56.338   Na                         C18H18N2O3    10
  137          6H-Dibenzo\[b,d\]pyran-1-ol, 6,6,9-trimethyl-3-pentyl-                              57.279   Cannabinol                 C21H26O2      10
  138          Sulfurous acid, pentadecyl 2-propyl ester                                           57.372   Na                         C18H38O3S     10
  139          Hexadecane, 2,6,10,14-tetramethyl                                                   57.927   Na                         C20H42        10
  140          Triacontane                                                                         59.093   Triacontane                C30H62        10
  141          P-Methyl-o-(phenylethynyl)phenol                                                    81.661   Na                         C15H12O       3

Acute toxicity
--------------

No mortality and behavioral change were observed at specified doses to confirm acute toxicity of the samples. According to the assay, dose up to 2,000 mg/kg was considered as safe for essential oil of *Isodon rugosus*.

Writhing test
-------------

A dose dependent response was observed in acetic acid induced writhing test for the assessment of analgesic activity. The mean writhes of the standard drug at 10 mg/kg, was 21.83 ± 0.60 with 70.29% inhibition. The essential oil sample exhibited mean inhibition of 31.50 ± 1.28 with 57.14% at 100 mg/kg, while, at 50 mg/kg it exhibited mean inhibition of 41.00 ± 0.57 with 44.21%. At 100 mg/kg, Ir.EO and positive control exhibited a response of 57.14 and 70.29% respectively as shown in Table [2](#T2){ref-type="table"}.

###### 

Percent anti-nociceptive potential of essential oil following acetic acid induced writhing model.

  **Samples**     **Dose (mg/kg)**   **Mean writhes**                                      **% Analgesic activity**
  --------------- ------------------ ----------------------------------------------------- --------------------------
  Negative cont   --                 73.50 ± 0.61                                          0.00
  Ir.Eo           50                 41.00 ± 0.57[^\*\*\*^](#TN2-1){ref-type="table-fn"}   44.21
  Ir.Eo           100                31.50 ± 1.28[^\*\*\*^](#TN2-1){ref-type="table-fn"}   57.14
  Positive cont   10                 21.83 ± 0.60[^\*\*\*^](#TN2-1){ref-type="table-fn"}   70.29

Ir.Eo, Essential oil isolated from Isodon rugosus; Mean writhes are represented as mean ± SEM.

*P \< 0.001*.

Formalin test
-------------

The results obtained from formalin test are shown in the Table [3](#T3){ref-type="table"}. The formalin injection (2%, i.p) to the animals revealed a typical biphasic licking response. In the control group, duration of licking was observed as 57.33 ± 0.88 and 67.00 ± 0.93 s for early (0--5 min) and late phase (15--30 min) respectively. Pre-treatment of mice with various concentrations of essential oil (50 and 100 mg/kg) produced a significant effect on the duration of licking in both phases. A dose of 100 mg/kg of Ir.EO brought a significant reduction in paw licking of 54.36 and 43.28% in early and late phase respectively. In comparison, the standard drug morphine (5 mg/kg i.p.) demonstrated overwhelming reduction in both phases, i.e., 79.36% (early phase/neurogenic pain) and 79.59% (late phase/inflammatory pain). The morphine in combination with naloxone exhibited 04.63 and 05.22% activity in early and late phase respectively. In comparison, Ir.EO in combination with naloxone revealed 09.01% (early phase) and 07.95% (late phase) pain inhibitions. So, the naloxone reversed the antinociceptive effect of essential oil considerably at dose of 100 mg/kg in both phases as those of morphine.

###### 

Effect of Essential oil of *Isodon rugosus* on formalin induced pain in mice.

  **Samples**      **Dose (mg/kg)**   **Total time spent in licking**                                                                                     
  ---------------- ------------------ ----------------------------------------------------- ------- ----------------------------------------------------- -------
  Negative cont.   --                 57.33 ± 0.88                                          --      67.00 ± 0.93                                          --
  Ir.Eo            50                 39.50 ± 1.11[^\*\*\*^](#TN3-3){ref-type="table-fn"}   31.10   49.67 ± 1.92[^\*\*\*^](#TN3-3){ref-type="table-fn"}   25.86
  Ir.Eo            100                26.16 ± 0.94[^\*\*\*^](#TN3-3){ref-type="table-fn"}   54.36   38.33 ± 0.71[^\*\*\*^](#TN3-3){ref-type="table-fn"}   43.28
  Mor              5                  11.83 ± 1.24[^\*\*\*^](#TN3-3){ref-type="table-fn"}   79.36   13.67 ± 0.67[^\*\*\*^](#TN3-3){ref-type="table-fn"}   79.59
  Mor + Nal        5 + 1              54.67 ± 1.02^ns^                                      04.63   63.50 ± 1.17^ns^                                      05.22
  Ir.Eo + Nal      50 + 1             52.16 ± 0.70[^\*\*^](#TN3-2){ref-type="table-fn"}     09.01   61.67 ± 1.14[^\*^](#TN3-1){ref-type="table-fn"}       07.95

Ir.Eo, Essential oil of Isodon rugosus; Mor, Morphine; Nal, Naloxone; Total time is represented as mean ± SEM.

*P \< 0.05*,

*P \< 0.01*,

*P \< 0.001*.

Hot plate test
--------------

The results obtained in the hot plate assay are shown in Table [4](#T4){ref-type="table"}. The Ir.EO revealed a dose dependent increase in the latency time as that of positive control. At 15 min, the mean reaction times for 50 and 100 mg/kg body weights of essential oil were observed as 06.40 ± 0.11 and 08.16 ± 0.08 min respectively. At 90 min, i.e., last interval, the mean reaction times of the same two doses were recorded as 04.40 ± 0.20 and 06.45 ± 0.07 min respectively. In comparison, the standard drug morphine exhibited reaction times of 12.41 ± 0.11 and 09.38 ± 0.08 min at initial and last interval respectively.

###### 

Effect of Essential oil of *Isodon rugosus* on hot plate induced pain in mice.

  **Samples**      **Dose (mg/kg)**                  **Reaction time on hot plate**                                 
  ---------------- ------------------ -------------- -------------------------------- -------------- -------------- --------------
  Negative cont.   --                 04.51 ± 0.10   02.43 ± 0.14                     03.55 ± 0.07   02.11 ± 0.15   03.20 ± 0.15
  Ir.Eo            50                 06.40 ± 0.11   04.18 ± 0.11                     05.76 ± 0.08   04.81 ± 0.14   04.40 ± 0.20
  Ir.Eo            100                08.16 ± 0.08   06.81 ± 0.13                     07.91 ± 0.11   06.80 ± 0.07   06.45 ± 0.07
  Mor              5                  12.41 ± 0.11   11.63 ± 0.06                     11.36 ± 0.08   10.45 ± 0.07   09.38 ± 0.08
  Mor + Nal        5 + 1              04.35 ± 0.13   02.80 ± 0.19                     04.35 ± 0.07   02.78 ± 0.10   03.56 ± 0.14
  Ir.Eo + Nal      50 + 1             05.28 ± 0.13   03.31 ± 0.08                     04.70 ± 0.08   03.11 ± 0.15   03.70 ± 0.05

*Ir.Eo: Essential oil of Isodon rugosus; Mor: Morphine; Nal: Naloxone; Total time is represented as mean ± SEM*.

Moreover, the recorded mean reaction time for Ir.EO with naloxone (50: 1 mg/kg) at 15 min was 05.28 ± 0.13 min. Similarly, for morphine and naloxone (5: 1 mg/kg), the mean reaction time observed was 04.35 ± 0.13 min at initial 15 min. In our experiment, we found a distinct reduction in reaction time with the administration of naloxone.

Involvement of opioid receptors
-------------------------------

In both hot plate and formalin models, we noticed that Ir.EO revealed a similar activity as that of morphine. The potency of Ir.EO was reduced effectively by opioid antagonist naloxone. With the use of naloxone, the decreased in reaction time in hot plate method and reversing the paw licking in formalin assay confirmed the possible involvement of opioid receptors.

Antioxidant assays
------------------

The antioxidant potential of Ir.EO using DPPH and ABTS free radicals scavenging methods are shown in Table [5](#T5){ref-type="table"}.

###### 

Antioxidant activity of essential oil of *Isodon rugosus* at various concentrations.

  **Test sample**   **Free radicals**   **Conc. 62.5 μg/ml**                                  **Conc. 125 μg/ml**                                   **Conc. 250 μg/ml**                                   **Conc. 500 μg/ml**                                   **Conc. 1,000 μg/ml**                                 **IC~50~ μg/ml**
  ----------------- ------------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ------------------
  EO                DPPH                33.00 ± 1.15[^\*\*\*^](#TN5-1){ref-type="table-fn"}   41.33 ± 0.88[^\*\*\*^](#TN5-1){ref-type="table-fn"}   46.33 ± 0.33[^\*\*\*^](#TN5-1){ref-type="table-fn"}   56.67 ± 0.67[^\*\*\*^](#TN5-1){ref-type="table-fn"}   63.67 ± 1.20[^\*\*\*^](#TN5-1){ref-type="table-fn"}   338
  EO                ABTS                39.67 ± 1.76[^\*\*\*^](#TN5-1){ref-type="table-fn"}   51.00 ± 0.57[^\*\*\*^](#TN5-1){ref-type="table-fn"}   56.67 ± 1.20[^\*\*\*^](#TN5-1){ref-type="table-fn"}   62.00 ± 0.57[^\*\*\*^](#TN5-1){ref-type="table-fn"}   64.33 ± 0.88[^\*\*\*^](#TN5-1){ref-type="table-fn"}   118
  A.A               DPPH                77.33 ± 0.88                                          79.67 ± 0.88                                          83.00 ± 1.73                                          86.33 ± 1.45                                          89.00 ± 1.73                                          \<62.5
  A.A               ABTS                75.00 ± 0.57                                          78.00 ± 1.15                                          81.67 ± 0.67                                          85.67 ± 0.33                                          91.33 ± 0.88                                          \<62.5

EO, Essential oil; A.A, Ascorbic acid.

*P \< 0.001*.

DPPH assay
----------

The observed percent inhibitions for Ir.EO using DPPH free radicals was 63.67 ± 1.20, 56.67 ± 0.67, 46.33 ± 0.33, 41.33 ± 0.88, and 33.00 ± 1.15% at concentrations of 1,000, 500, 250, 125, and 62.5 μg/ml respectively. The calculated IC~50~ value from the dose response curve was 338 μg/ml. In comparison, the standard drug ascorbic acid exhibited 89.00 ± 1.73, 86.33 ± 1.45, 83.00 ± 1.73, 79.67 ± 0.88, and 77.33 ± 0.88% inhibitions at 1,000, 500, 250, 125, and 62.5 μg/ml respectively with an IC~50~ value of \<0.1 μg/ml.

ABTS assay
----------

In ABTS assay, Ir.EO attained 64.33 ± 0.88, 62.00 ± 0.57, 56.67 ± 1.20, 51.00 ± 0.57, and 39.67 ± 1.76% inhibitions at 1,000, 500, 250, 125, and 62.5 μg/ml respectively. The calculated IC~50~ for Ir.EO in scavenging ABTS free radicals was 118 μg/ml. In this assay, ascorbic acid demonstrated 91.33 ± 0.88, 85.67 ± 0.33, 81.67 ± 0.67, 78.00 ± 1.15, and 75.00 ± 0.57% inhibitions at 1,000, 500, 250, 125, and 62.5 μg/ml respectively attaining an IC~50~ value of \<0.1 μg/ml.

Cholinesterase inhibition assay
-------------------------------

In AChE inhibitory assay, Ir.EO exhibited concentration dependent inhibitions against the enzymes (Table [6](#T6){ref-type="table"}). Ir.EO showed 67.50 ± 1.04% AChE inhibition at 1.0 mg/ml concentration with IC~50~ of 93.56 μg/ml. Similarly, the observed inhibitory potential against BChE at the same tested concentration as AChE was 61.33 ± 0.67% with an IC~50~ of 284.19 μg/ml. In comparison, the standard drug galanthamine exhibited 0.371 and 3.324 μg/ml IC~50~ against AChE and BChE respectively.

###### 

Anticholinesterase activity of essential oil of *Isodon rugosus* at various concentrations.

  **Test sample**   **Enzymes**   **Conc. 62.5 μg/ml**   **Conc. 125 μg/ml**   **Conc. 250 μg/ml**   **Conc. 500 μg/ml**   **Conc. 1,000 μg/ml**   **IC~50~ μg/ml**
  ----------------- ------------- ---------------------- --------------------- --------------------- --------------------- ----------------------- ------------------
  E.Oil             AChE          42.30 ± 0.47           56.46 ± 1.27          57.00 ± 0.57          62.67 ± 0.88          67.50 ± 1.04            93.56
  E.Oil             BChE          36.56 ± 0.97           41.95 ± 2.01          49.87 ± 1.67          56.00 ± 1.15          61.33 ± 0.67            284.19
  Gal               AChE          74.00 ± 1.00           79.66 ± 1.85          85.00 ± 1.73          87.46 ± 1.79          94.83 ± 1.92            \<62.5
  Gal               BChE          63.83 ± 0.92           71.16 ± 0.92          77.83 ± 1.09          83.16 ± 1.42          88.00 ± 1.25            \<62.5

*Data is expressed as Mean±SEM; Gal and E.Oil are abbreviated for Galanthamine and Essential oil respectively*.

Discussion {#s4}
==========

In our designed work, the essential oil of *I. rugosus* was evaluated for antinociceptive, antioxidant, and anticholinestease potentials. The essential oils of plants are sources of wide variety of bioactive compounds (Dehpour et al., [@B27]). The pharmacological potentials of essential oil can be attributed to the hydropholic nature of its components and the same nature of our body cell membranes (Ait-Ouazzou et al., [@B6]). Various components of essential oils can easily get distributed to different compartments of our body including the central nervous system (Lambert et al., [@B42]; Vyas et al., [@B63]). In our current investigational study, the antinociceptive potential of essential oil was recorded with significant results. The possible mechanism of antinociceptive activity of Ir.EO was figured out as the central pathway due to involvement of opioid receptors. Recently, we have also reported the antinociceptive potential of chloroform fraction of *I. rugosus* following the same mechanism. The antinociceptive potential of essential oil may be due to the presence of large number of bioactive compounds as obvious from its GC-MS analysis. Among the identified compounds, we also observed some of the bioactive compounds previously reported with analgesic potentials. These compounds include α-copaene, germacrene D, β-caryophyllene, α-caryophyllene, aromadendrene, calamenene, viridiflorol, mansonone C, t-muurolol, α-cadinol, azunol, phytol, neophytadiene, and simvastatin. In short, α-copaene has been reported to possess strong analgesic and antioxidant potentials (Him et al., [@B34]; Chen et al., [@B22]; Costa et al., [@B24]). Likewise, germacrene D also possesses analgesic and antioxidant effects (Del-Vechio-Vieira et al., [@B28]; Victoria et al., [@B61]). β-Caryophyllene is also reported with its analgesic and antioxidant potentials (Calleja et al., [@B19]; Klauke et al., [@B41]). The antinociceptive activity of aromadendrene has also been demonstrated (Cruz et al., [@B25]). Similarly, α-caryophyllene has been reported for the treatment of body inflammatory pain (Pianowski et al., [@B45]). The analgesic and antioxidant effects of calamenene have also been demonstrated with significant results (Azevedo et al., [@B16]; Imam et al., [@B36]). Viridiflorol, a well-known bioactive compound is also reported to possess analgesic and radical scavenging potentials (Perry et al., [@B44]; do Amaral et al., [@B29]). Moreover, Mansonone C (including its reduced form) is also responsible for direct antioxidant activity (Villamil et al., [@B62]). T-muurolol has been verified for inhibitory activity against DPPH free radicals (Cheng et al., [@B23]). The analgesic activity of α-cadinol has also been reported with notable results (Boutaghane et al., [@B17]). The antinociceptive aspects of azunol has also been published previously (Ushiyama et al., [@B60]). In the same way, ledene has also been reported to possess analgesic activity (Alagammal et al., [@B9]). A well-known compound, i.e., phytol, is famous for its antioxidant potential along with its antinoceptive potential (Santos et al., [@B50]). Neophytadiene is also among the famous analgesic and antioxidant candidates (Jayashree et al., [@B38]). Similarly, simvastatin is also previously reported with its analgesic and antioxidant potentials (Carneado et al., [@B20]; Chen et al., [@B21]).

Literature review and the results of our current investigations go parallel with sound correlation. The traditional use of *I. rugosus* as analgesic is efficiently verified in the current research project, along with the identification of bioactive compounds.

Beside the antioxidant potential of Ir.EO, we also evaluated its AChE and BChE inhibitory potentials. Among other pathological targets of Alzheimer disease, inhibitions of cholinesterase and free radicals are also vital targets. Among the clinically approved anti-Alzheimer drugs, four are cholinesterase inhibitors, which signify the importance of this target in the symptomatic management of the disease. In the current study, we observed a moderate *in-vitro* cholinesterase inhibitory activity of Ir.EO. In AChE and BChE inhibitory assays, Ir.EO showed concentration dependent inhibitions against the enzymes with IC~50~ values of 93.56 and 284.19 μg/ml respectively. Though the *in-vitro* enzyme inhibitory activity of essential oil was low in comparison to galanthamine, yet, we hypothesize that it will have more availability at the target site. However, further studies are required regarding *in-vivo* efficacy of our tested essential oil.

Conclusion {#s5}
==========

Based on the literature survey regarding the medicinal aspects of *I. rugosus* and the results of current investigational study, it may be deduced that the essential oil of *I. rugosus* is a good source of natural bioactive compounds containing numerous analgesic and antioxidant agents. Its antioxidant potentials along with cholinesterase inhibitory activity will be potentially effective in the management of Alzheimer\'s disease patients. It may also be inferred that further exploitation of essential oil of *I. rugosus* may lead to the development of new analgesic and/or anti-Alzheimer drug candidates.
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